Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: Is device implantation justified?

被引:18
作者
Russo, AM [1 ]
Nayak, H [1 ]
Verdino, R [1 ]
Springman, J [1 ]
Gerstenfeld, E [1 ]
Hsia, H [1 ]
Marchlinski, FE [1 ]
机构
[1] Univ Penn, Hlth Syst, Presbyterian Med Ctr, Philadelphia, PA 19104 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2003年 / 26卷 / 12期
关键词
implantable defibrillator; coronary disease; ventricular tachycardia;
D O I
10.1111/j.1540-8159.2003.00361.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary prevention trials have demonstrated that patients with coronary disease, reduced left ventricular function, and nonsustained ventricular tachycardia (NSVT) have improved survival with implantable cardioverter defibrillator (ICD) therapy, presumably secondary to effective termination of life-threatening arrhythmias. However, stored intracardiac electrograms were not always available and specific arrhythmias leading to ICD therapy were not always known. We examined the occurrence of ICD events in 51 consecutive patients who match the described patient profile to determine the frequency of appropriate and inappropriate ICD therapy. ICD detections were noted in 18 (35%) patients during a median follow-up period of 13.1 months. Appropriate therapy for sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) occurred in 11 (22%) patients, with appropriate shocks in 8 (16%) patients and appropriate antitachycardia pacing (ATP) in 4 (8%) patients. The time to first appropriate therapy occurred at a mean of 17 +/- 12 months (median 18 months, range 3-36 months). Inappropriate therapy occurred in 5 (10%) patients with inappropriate shocks in 4 patients and inappropriate ATP in 2 patients. Inappropriate therapy was delivered for supraventricular arrhythmias (SVAs) in 4 patients and for T wave oversensing in 1 patient. The reason for shock therapy was unknown in 1 patient (2%) due to ICD malfunction. The mean arrhythmia rate leading to appropriate therapy for VT/VF was 232 +/- 72 beats/min (range 181-400 beats/min), and the mean rate leading to inappropriate therapy for SVT was 168 +/- 10 beats/min (range 160-180 beats/min). Patients with coronary disease and asymptomatic NSVT commonly receive appropriate defibrillator therapy. These results support the need for ICD implantation for primary prevention, with attention to careful programming of the detection rate to prevent inappropriate therapy.
引用
收藏
页码:2289 / 2295
页数:7
相关论文
共 41 条
[1]   Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias - A comparison with patients known to have sustained ventricular tachycardia [J].
Andrews, NP ;
Fogel, RI ;
Pelargonio, G ;
Evans, JJ ;
Prystowsky, EN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :2023-2030
[2]   ACUTE EFFICACY AND CHRONIC FOLLOW-UP OF PATIENTS WITH NON-THORACOTOMY 3RD GENERATION IMPLANTABLE DEFIBRILLATORS [J].
BRACHMANN, J ;
STERNS, LD ;
HILBEL, T ;
SCHOELS, W ;
BEYER, T ;
MEHMANESH, H ;
LANGE, R ;
RUFRICHTER, J ;
KRAFT, P ;
HAGL, S ;
KUBLER, W .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (03) :499-505
[3]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[4]   TIME TO 1ST PULSE AFTER AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION [J].
CURTIS, JJ ;
WALLS, JT ;
BOLEY, TM ;
STEPHENSON, HE ;
SCHMALTZ, RA ;
NAWARAWONG, W ;
FLAKER, GC .
ANNALS OF THORACIC SURGERY, 1992, 53 (06) :984-987
[5]   CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
ECHT, DS ;
ARMSTRONG, K ;
SCHMIDT, P ;
OYER, PE ;
STINSON, EB ;
WINKLE, RA .
CIRCULATION, 1985, 71 (02) :289-296
[6]   ACTUARIAL INCIDENCE AND PATTERN OF OCCURRENCE OF SHOCKS FOLLOWING IMPLANTATION OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
FOGOROS, RN ;
ELSON, JJ ;
BONNET, CA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (09) :1465-1473
[7]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN DRUG-REFRACTORY VENTRICULAR TACHYARRHYTHMIAS [J].
FOGOROS, RN ;
FIEDLER, SB ;
ELSON, JJ .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :635-641
[8]   Improved survival in patients with nonischemic advanced heart failure and syncope treated with implantable cardioverter-defibrillator [J].
Fonarow, GC ;
Feliciano, Z ;
Boyle, NG ;
Knight, L ;
Woo, MA ;
Moriguchi, JD ;
Laks, H ;
Wiener, I .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (08) :981-985
[9]   EFFICACY OF AUTOMATIC MULTIMODAL DEVICE THERAPY FOR VENTRICULAR TACHYARRHYTHMIAS AS DELIVERED BY A NEW IMPLANTABLE PACING CARDIOVERTER-DEFIBRILLATOR - RESULTS OF A EUROPEAN MULTICENTER STUDY OF 102 IMPLANTS [J].
FROMER, M ;
BRACHMANN, J ;
BLOCK, M ;
SIEBELS, J ;
HOFFMANN, E ;
ALMENDRAL, J ;
OHM, OJ ;
DENDULK, K ;
COUMEL, P ;
CAMM, AJ ;
TOUBOUL, P .
CIRCULATION, 1992, 86 (02) :363-374
[10]   AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - PATIENT SURVIVAL, BATTERY LONGEVITY AND SHOCK DELIVERY ANALYSIS [J].
GABRY, MD ;
BRODMAN, R ;
JOHNSTON, D ;
FRAME, R ;
KIM, SG ;
WASPE, LE ;
FISHER, JD ;
FURMAN, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (06) :1349-1356